✦ LIBER ✦

Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus

✍ Scribed by K. A. Finucane; C. B. Archer

Book ID: 108693320
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 63 KB
Volume: 30
Category: Article
ISSN: 0307-6938
DOI: 10.1111/j.1365-2230.2005.01731.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autoantibodies to the nuclear antigen hn

Autoantibodies to the nuclear antigen hnRNP-A2 (RA33) in animal models of rheumatoid arthritis and systemic lupus erythematosus

✍ G. Steiner; K. Skriner; D. Plows; G. Kollias; P. Cohen; I. Fischer; J.S. Smolen 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Effect of treatment with biological agen

Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database

✍ R. Buchbinder; L. March; M. Lassere; A. M. Briggs; I. Portek; C. Reid; A. Meehan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

A practical guide for the use of biologi

A practical guide for the use of biologic agents in the treatment of rheumatoid arthritis*

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Preliminary criteria for the classificat

Preliminary criteria for the classification of systemic lupus erythematosus (SLE) evaluation in early diagnosed SLE and rheumatoid arthritis

✍ R. Bruce Trimble; Alexander S. Townes; Harry Robinson; Stanley B. Kaplan; Robert 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB 👁 3 views

No evidence of association between anti–

No evidence of association between anti–tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register

✍ Mark Lunt; Kath D. Watson; William G. Dixon; British Society for Rheumatology Bi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

## Objective To study the association between anti–tumor necrosis factor (anti-TNF) therapy and mortality in a national cohort of patients with rheumatoid arthritis. ## Methods We prospectively followed up 12,672 patients who were beginning anti-TNF therapy and 3,522 biologic-naive patients recei

Regression of subacute cutaneous lupus e

Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor α–blocking agent: Comment on the article by Pisetsky and the letter from Aringer et al

✍ Bruno Fautrel; Violaine Foltz; Camille Frances; Pierre Bourgeois; Sylvie Rozenbe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 700 KB